Intensity Therapeutics (INTS) Other Non-Current Liabilities (2022 - 2024)
Intensity Therapeutics' (INTS) quarterly Other Non-Current Liabilities came in at $36000.0 in Q1 2024, little changed on a QoQ basis from $36000.0 in Q4 2023.
Intensity Therapeutics (INTS) Other Non-Current Liabilities (2022 - 2024) Analysis & Trends
Intensity Therapeutics (INTS) has 3 years of Other Non-Current Liabilities data on file, last reported at $36000.0 in Q1 2024.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $36000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $36000.0 (changed N/A YoY) and the FY2023 annual result came in at $36000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities steadied at $36000.0 in Q1 2024, from $36000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $36000.0 in Q4 2022 to a low of $36000.0 in Q4 2022.
- A 3-year average of $36000.0 and a median of $36000.0 in 2022 frame the typical range for Other Non-Current Liabilities.
- The widest YoY moves for Other Non-Current Liabilities: up 0.0% in 2023, down 0.0% in 2023.
- Tracing INTS's Other Non-Current Liabilities over 3 years: stood at $36000.0 in 2022, then changed by 0.0% to $36000.0 in 2023, then changed by 0.0% to $36000.0 in 2024.
- The last three Other Non-Current Liabilities figures came in at $36000.0 (Q1 2024), $36000.0 (Q4 2023), and $36000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Intensity Therapeutics | 13.06 Mn | 13.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 36,000.00 |
| Dec 31, 2023 | 36,000.00 |
| Sep 30, 2023 | 36,000.00 |
| Dec 31, 2022 | 36,000.00 |